Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
Scientific Community
Become a Member | Sign in
Home>News>This Article

Intelsius Introduces Revised PharmaTherm™ Solutions

Published: Wednesday, January 29, 2014
Last Updated: Wednesday, January 29, 2014
Bookmark and Share
Company introduces PharmaTherm™ solutions at the 13th Annual Cool Chain Europe Summit in Luxembourg.

Intelsius has introduced revisions to its PharmaTherm™ line of solutions to pharmaceutical industry professionals at the 13th Annual Cool Chain Europe Summit in Luxembourg.

“Intelsius is refining one of our best-selling product lines to stay ahead of the constantly changing pharmaceutical industry,” said David Walsh, CEO, Intelsius. “All three new sizes provide optimal thermal protection for pharmaceutical products.”

PharmaTherm R solutions are regulatory compliant to meet the qualifications in the new GDP Guidelines for the EU that expanded and became more uniformly regulated in September 2013.

PharmaTherm R solutions are pre-qualified to the Intelsius High Performance profile and maintain payload integrity during shipments for 72 hours. The three sizes available utilize the same size coolant across the range and have a universal pack out making them easy to assemble, operationally friendly, tamper-evident and economical to ship.

“These additions allow more flexibility in payload sizes making them an Intelsius innovation,” said Steve Healy, Intelsius global director of sales. With interchangeable components and common features across the range, suitable solutions are available for all temperature controlled shipping requirements. The PharmaTherm family now offers pre-qualified 72 hour 2-8 degrees C, 96 hour 15-25 degrees C, PCM and dry ice solutions.

“The revised PharmaTherm line of products will help our customers save on storage space and shipping costs,” said Walsh. “As we continue to protect life’s most precious cargo we create innovative products that provide intelligent solutions.”

PharmaTherm products maintain appropriate temperatures and keep products safe while being transported. In addition, its discreet design keeps the contents confidential.

Intelsius serves a wide range of organizations including government agencies, leading pharmaceutical, biopharmaceutical and clinical research industries to major laboratories. Intelsius is the preferred response partner for human and veterinary epidemic and pandemic events in the UK and the Republic of Ireland.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
ALS Study Reveals Role of RNA-Binding Proteins
The findings are a significant step forward in validating RNA-based therapy as a treatment for ALS.
Gene Therapy Going Global with Portable Device
Portable 'gene therapy in a box' could make future cancer and HIV cures affordable in developing countries.
RNA-Binding Proteins Role in ALS Revealed
Researchers describe how damage to RNA-binding protein contributes to ALS, isolating a possible therapeutic target.
Genome Engineering Paves Way For Sickle Cell Cure
Researchers from UC Berkeley have used CRISPR-Cas9 gene editing to fix the mutated gene responsible for sickle cell disease.
Preventing Alzheimer's in Mice
Researchers have prevented the Alzheimer’s development in mice by using a virus delivery system to transport a specific gene into the brain.
Link Between Heart and Blood Cells in Early Development Found
Researchers have identifed a key factor in determining the fate of early undifferentiated cells during development.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Scientists Speed Up Muscle Repair
Researchers discovered genetically modified mice were able to support far more regenerative stem cells, for muscle repair, than previously thought.
Nanosensors Could Determine Tumours’ Ability to Remodel Tissue
Researchers design nanosensors that can profile tumours, focusing on protease levels.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos